Cell based assay for identifying sh2-domain-specific signal transducer antagonist
AssigneeARIAD Pharmaceuticals, Inc.
InventorRichard J. Rickles
Life of this patent
Estimating the term…
Abstract
The present invention provides methods and compositions for identifying inhibitors of the interaction between phosphopeptide binding pairs, i.e., a protein domain having at least one phosphopeptide binding domain and the phosphorylated ligands that bind these domains. These inhibitors may be used for pharmaceutical compositions and in therapeutic treatments for diseases in which a phosphopeptide domain binding is implicated.
Claims11
A method for identifying the presence in a test composition of an inhibitor of the binding of a phosphopeptide binding pair comprising either a phosphatase domain and a ligand therefor or a phosphotyrosine binding domain and a ligand therefor, which method comprises the steps of:
- (a) providing mammalian cells which contain and are capable of expressing recombinant DNA molecules encoding two fusion proteins, the first of which comprising one or more copies of each of a transcription activation domain and one member of the phosphopeptide binding pair, the second of which comprising one or more copies of each of a DNA-binding domain and the other member of the phosphopeptide binding pair, wherein the cells
- (i) further contain a reporter gene which encodes a detectable gene product and is linked to a DNA sequence permitting expression of the reporter gene in the presence of the pair of fusion proteins, and
- ii) when cultured are capable of producing measurable amounts of said detectable gene product,
- (b) culturing said cells in the presence and absence of the test composition under conditions in which, in the absence of an inhibitor of the binding of the phosphopeptide binding pair they produce measurable amounts of said detectable gene product, and
- (c) determining whether production of the detectable gene product was diminished in the presence of the test composition which would indicate the presence of an inhibitor.
Dependencies are inferred from the claim text.